Table of Content

1 Human Papillomavirus Protein E7 Market Overview
1.1 Human Papillomavirus Protein E7 Product Scope
1.2 Human Papillomavirus Protein E7 Segment by Type
1.2.1 Global Human Papillomavirus Protein E7 Sales by Type (2016 & 2021 & 2027)
1.2.2 CUE-201
1.2.3 BLSILSB-710c
1.2.4 CerviVax
1.2.5 CUE-101
1.2.6 Others
1.3 Human Papillomavirus Protein E7 Segment by Application
1.3.1 Global Human Papillomavirus Protein E7 Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Anal Cancer
1.3.3 Lung Cancer
1.3.4 Penile Cancer
1.3.5 Rectal Cancer
1.3.6 Others
1.4 Human Papillomavirus Protein E7 Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Papillomavirus Protein E7 Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Papillomavirus Protein E7 Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Papillomavirus Protein E7 Price Trends (2016-2027)

2 Human Papillomavirus Protein E7 Estimates and Forecasts by Region
2.1 Global Human Papillomavirus Protein E7 Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Papillomavirus Protein E7 Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Papillomavirus Protein E7 Sales Market Share by Region (2016-2021)
2.2.2 Global Human Papillomavirus Protein E7 Revenue Market Share by Region (2016-2021)
2.3 Global Human Papillomavirus Protein E7 Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Papillomavirus Protein E7 Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Papillomavirus Protein E7 Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Papillomavirus Protein E7 Estimates and Projections (2016-2027)
2.4.2 Europe Human Papillomavirus Protein E7 Estimates and Projections (2016-2027)
2.4.3 China Human Papillomavirus Protein E7 Estimates and Projections (2016-2027)
2.4.4 Japan Human Papillomavirus Protein E7 Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Papillomavirus Protein E7 Estimates and Projections (2016-2027)
2.4.6 India Human Papillomavirus Protein E7 Estimates and Projections (2016-2027)

3 Global Human Papillomavirus Protein E7 Competition Landscape by Players
3.1 Global Top Human Papillomavirus Protein E7 Players by Sales (2016-2021)
3.2 Global Top Human Papillomavirus Protein E7 Players by Revenue (2016-2021)
3.3 Global Human Papillomavirus Protein E7 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Papillomavirus Protein E7 as of 2020)
3.4 Global Human Papillomavirus Protein E7 Average Price by Company (2016-2021)
3.5 Manufacturers Human Papillomavirus Protein E7 Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Human Papillomavirus Protein E7 Market Size by Type
4.1 Global Human Papillomavirus Protein E7 Historic Market Review by Type (2016-2021)
4.1.1 Global Human Papillomavirus Protein E7 Sales Market Share by Type (2016-2021)
4.1.2 Global Human Papillomavirus Protein E7 Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Papillomavirus Protein E7 Price by Type (2016-2021)
4.2 Global Human Papillomavirus Protein E7 Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Papillomavirus Protein E7 Sales Forecast by Type (2022-2027)
4.2.2 Global Human Papillomavirus Protein E7 Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Papillomavirus Protein E7 Price Forecast by Type (2022-2027)

5 Global Human Papillomavirus Protein E7 Market Size by Application
5.1 Global Human Papillomavirus Protein E7 Historic Market Review by Application (2016-2021)
5.1.1 Global Human Papillomavirus Protein E7 Sales Market Share by Application (2016-2021)
5.1.2 Global Human Papillomavirus Protein E7 Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Papillomavirus Protein E7 Price by Application (2016-2021)
5.2 Global Human Papillomavirus Protein E7 Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Papillomavirus Protein E7 Sales Forecast by Application (2022-2027)
5.2.2 Global Human Papillomavirus Protein E7 Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Papillomavirus Protein E7 Price Forecast by Application (2022-2027)

6 North America Human Papillomavirus Protein E7 Market Facts & Figures
6.1 North America Human Papillomavirus Protein E7 Sales by Company
6.1.1 North America Human Papillomavirus Protein E7 Sales by Company (2016-2021)
6.1.2 North America Human Papillomavirus Protein E7 Revenue by Company (2016-2021)
6.2 North America Human Papillomavirus Protein E7 Sales Breakdown by Type
6.2.1 North America Human Papillomavirus Protein E7 Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Papillomavirus Protein E7 Sales Breakdown by Type (2022-2027)
6.3 North America Human Papillomavirus Protein E7 Sales Breakdown by Application
6.3.1 North America Human Papillomavirus Protein E7 Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Papillomavirus Protein E7 Sales Breakdown by Application (2022-2027)

7 Europe Human Papillomavirus Protein E7 Market Facts & Figures
7.1 Europe Human Papillomavirus Protein E7 Sales by Company
7.1.1 Europe Human Papillomavirus Protein E7 Sales by Company (2016-2021)
7.1.2 Europe Human Papillomavirus Protein E7 Revenue by Company (2016-2021)
7.2 Europe Human Papillomavirus Protein E7 Sales Breakdown by Type
7.2.1 Europe Human Papillomavirus Protein E7 Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Papillomavirus Protein E7 Sales Breakdown by Type (2022-2027)
7.3 Europe Human Papillomavirus Protein E7 Sales Breakdown by Application
7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)

8 China Human Papillomavirus Protein E7 Market Facts & Figures
8.1 China Human Papillomavirus Protein E7 Sales by Company
8.1.1 China Human Papillomavirus Protein E7 Sales by Company (2016-2021)
8.1.2 China Human Papillomavirus Protein E7 Revenue by Company (2016-2021)
8.2 China Human Papillomavirus Protein E7 Sales Breakdown by Type
8.2.1 China Human Papillomavirus Protein E7 Sales Breakdown by Type (2016-2021)
8.2.2 China Human Papillomavirus Protein E7 Sales Breakdown by Type (2022-2027)
8.3 China Human Papillomavirus Protein E7 Sales Breakdown by Application
8.3.1 China 161 Sales Breakdown by Application (2016-2021)
8.3.2 China 161 Sales Breakdown by Application (2022-2027)

9 Japan Human Papillomavirus Protein E7 Market Facts & Figures
9.1 Japan Human Papillomavirus Protein E7 Sales by Company
9.1.1 Japan Human Papillomavirus Protein E7 Sales by Company (2016-2021)
9.1.2 Japan Human Papillomavirus Protein E7 Revenue by Company (2016-2021)
9.2 Japan Human Papillomavirus Protein E7 Sales Breakdown by Type
9.2.1 Japan Human Papillomavirus Protein E7 Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Papillomavirus Protein E7 Sales Breakdown by Type (2022-2027)
9.3 Japan Human Papillomavirus Protein E7 Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Human Papillomavirus Protein E7 Market Facts & Figures
10.1 Southeast Asia Human Papillomavirus Protein E7 Sales by Company
10.1.1 Southeast Asia Human Papillomavirus Protein E7 Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Papillomavirus Protein E7 Revenue by Company (2016-2021)
10.2 Southeast Asia Human Papillomavirus Protein E7 Sales Breakdown by Type
10.2.1 Southeast Asia Human Papillomavirus Protein E7 Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Papillomavirus Protein E7 Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Papillomavirus Protein E7 Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Human Papillomavirus Protein E7 Market Facts & Figures
11.1 India Human Papillomavirus Protein E7 Sales by Company
11.1.1 India Human Papillomavirus Protein E7 Sales by Company (2016-2021)
11.1.2 India Human Papillomavirus Protein E7 Revenue by Company (2016-2021)
11.2 India Human Papillomavirus Protein E7 Sales Breakdown by Type
11.2.1 India Human Papillomavirus Protein E7 Sales Breakdown by Type (2016-2021)
11.2.2 India Human Papillomavirus Protein E7 Sales Breakdown by Type (2022-2027)
11.3 India Human Papillomavirus Protein E7 Sales Breakdown by Application
11.3.1 India Human Papillomavirus Protein E7 Sales Breakdown by Application (2016-2021)
11.3.2 India Human Papillomavirus Protein E7 Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Human Papillomavirus Protein E7 Business
12.1 Abion Inc
12.1.1 Abion Inc Corporation Information
12.1.2 Abion Inc Business Overview
12.1.3 Abion Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Abion Inc Human Papillomavirus Protein E7 Products Offered
12.1.5 Abion Inc Recent Development
12.2 Advaxis Inc
12.2.1 Advaxis Inc Corporation Information
12.2.2 Advaxis Inc Business Overview
12.2.3 Advaxis Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Advaxis Inc Human Papillomavirus Protein E7 Products Offered
12.2.5 Advaxis Inc Recent Development
12.3 Bioleaders Corp
12.3.1 Bioleaders Corp Corporation Information
12.3.2 Bioleaders Corp Business Overview
12.3.3 Bioleaders Corp Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bioleaders Corp Human Papillomavirus Protein E7 Products Offered
12.3.5 Bioleaders Corp Recent Development
12.4 BioNTech AG
12.4.1 BioNTech AG Corporation Information
12.4.2 BioNTech AG Business Overview
12.4.3 BioNTech AG Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.4.4 BioNTech AG Human Papillomavirus Protein E7 Products Offered
12.4.5 BioNTech AG Recent Development
12.5 Cancer Research Technology Ltd
12.5.1 Cancer Research Technology Ltd Corporation Information
12.5.2 Cancer Research Technology Ltd Business Overview
12.5.3 Cancer Research Technology Ltd Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Cancer Research Technology Ltd Human Papillomavirus Protein E7 Products Offered
12.5.5 Cancer Research Technology Ltd Recent Development
12.6 Etubics Corp
12.6.1 Etubics Corp Corporation Information
12.6.2 Etubics Corp Business Overview
12.6.3 Etubics Corp Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Etubics Corp Human Papillomavirus Protein E7 Products Offered
12.6.5 Etubics Corp Recent Development
12.7 Formune SL
12.7.1 Formune SL Corporation Information
12.7.2 Formune SL Business Overview
12.7.3 Formune SL Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Formune SL Human Papillomavirus Protein E7 Products Offered
12.7.5 Formune SL Recent Development
12.8 Genexine Inc
12.8.1 Genexine Inc Corporation Information
12.8.2 Genexine Inc Business Overview
12.8.3 Genexine Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Genexine Inc Human Papillomavirus Protein E7 Products Offered
12.8.5 Genexine Inc Recent Development
12.9 Hookipa Biotech AG
12.9.1 Hookipa Biotech AG Corporation Information
12.9.2 Hookipa Biotech AG Business Overview
12.9.3 Hookipa Biotech AG Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hookipa Biotech AG Human Papillomavirus Protein E7 Products Offered
12.9.5 Hookipa Biotech AG Recent Development
12.10 iBio Inc
12.10.1 iBio Inc Corporation Information
12.10.2 iBio Inc Business Overview
12.10.3 iBio Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.10.4 iBio Inc Human Papillomavirus Protein E7 Products Offered
12.10.5 iBio Inc Recent Development
12.11 Immunovaccine Inc
12.11.1 Immunovaccine Inc Corporation Information
12.11.2 Immunovaccine Inc Business Overview
12.11.3 Immunovaccine Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Immunovaccine Inc Human Papillomavirus Protein E7 Products Offered
12.11.5 Immunovaccine Inc Recent Development
12.12 Inovio Pharmaceuticals Inc
12.12.1 Inovio Pharmaceuticals Inc Corporation Information
12.12.2 Inovio Pharmaceuticals Inc Business Overview
12.12.3 Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Products Offered
12.12.5 Inovio Pharmaceuticals Inc Recent Development
12.13 MedImmune LLC
12.13.1 MedImmune LLC Corporation Information
12.13.2 MedImmune LLC Business Overview
12.13.3 MedImmune LLC Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.13.4 MedImmune LLC Human Papillomavirus Protein E7 Products Offered
12.13.5 MedImmune LLC Recent Development
12.14 Selecta Biosciences Inc
12.14.1 Selecta Biosciences Inc Corporation Information
12.14.2 Selecta Biosciences Inc Business Overview
12.14.3 Selecta Biosciences Inc Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Selecta Biosciences Inc Human Papillomavirus Protein E7 Products Offered
12.14.5 Selecta Biosciences Inc Recent Development
12.15 Touchlight Genetics Ltd
12.15.1 Touchlight Genetics Ltd Corporation Information
12.15.2 Touchlight Genetics Ltd Business Overview
12.15.3 Touchlight Genetics Ltd Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Touchlight Genetics Ltd Human Papillomavirus Protein E7 Products Offered
12.15.5 Touchlight Genetics Ltd Recent Development
12.16 Transgene SA
12.16.1 Transgene SA Corporation Information
12.16.2 Transgene SA Business Overview
12.16.3 Transgene SA Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Transgene SA Human Papillomavirus Protein E7 Products Offered
12.16.5 Transgene SA Recent Development
12.17 VLPbio
12.17.1 VLPbio Corporation Information
12.17.2 VLPbio Business Overview
12.17.3 VLPbio Human Papillomavirus Protein E7 Sales, Revenue and Gross Margin (2016-2021)
12.17.4 VLPbio Human Papillomavirus Protein E7 Products Offered
12.17.5 VLPbio Recent Development

13 Human Papillomavirus Protein E7 Manufacturing Cost Analysis
13.1 Human Papillomavirus Protein E7 Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Papillomavirus Protein E7
13.4 Human Papillomavirus Protein E7 Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Papillomavirus Protein E7 Distributors List
14.3 Human Papillomavirus Protein E7 Customers

15 Market Dynamics
15.1 Human Papillomavirus Protein E7 Market Trends
15.2 Human Papillomavirus Protein E7 Drivers
15.3 Human Papillomavirus Protein E7 Market Challenges
15.4 Human Papillomavirus Protein E7 Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Papillomavirus Protein E7 Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Papillomavirus Protein E7 Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Papillomavirus Protein E7 Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Papillomavirus Protein E7 Sales (K Pcs) by Region (2016-2021)
Table 5. Global Human Papillomavirus Protein E7 Sales Market Share by Region (2016-2021)
Table 6. Global Human Papillomavirus Protein E7 Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Papillomavirus Protein E7 Revenue Share by Region (2016-2021)
Table 8. Global Human Papillomavirus Protein E7 Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Human Papillomavirus Protein E7 Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Papillomavirus Protein E7 Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Papillomavirus Protein E7 Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Papillomavirus Protein E7 Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Human Papillomavirus Protein E7 Sales Share by Company (2016-2021)
Table 14. Global Human Papillomavirus Protein E7 Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Papillomavirus Protein E7 Revenue Share by Company (2016-2021)
Table 16. Global Human Papillomavirus Protein E7 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Papillomavirus Protein E7 as of 2020)
Table 17. Global Human Papillomavirus Protein E7 Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Human Papillomavirus Protein E7 Manufacturing Sites and Area Served
Table 19. Manufacturers Human Papillomavirus Protein E7 Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Papillomavirus Protein E7 Sales (K Pcs) by Type (2016-2021)
Table 22. Global Human Papillomavirus Protein E7 Sales Share by Type (2016-2021)
Table 23. Global Human Papillomavirus Protein E7 Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Papillomavirus Protein E7 Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Human Papillomavirus Protein E7 Sales Share by Type (2022-2027)
Table 26. Global Human Papillomavirus Protein E7 Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Papillomavirus Protein E7 Revenue Share by Type (2022-2027)
Table 28. Global Human Papillomavirus Protein E7 Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Human Papillomavirus Protein E7 Sales (K Pcs) by Application (2016-2021)
Table 30. Global Human Papillomavirus Protein E7 Sales Share by Application (2016-2021)
Table 31. Global Human Papillomavirus Protein E7 Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Papillomavirus Protein E7 Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Human Papillomavirus Protein E7 Sales (K Pcs) by Application (2022-2027)
Table 34. Global Human Papillomavirus Protein E7 Sales Share by Application (2022-2027)
Table 35. Global Human Papillomavirus Protein E7 Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Papillomavirus Protein E7 Revenue Share by Application (2022-2027)
Table 37. Global Human Papillomavirus Protein E7 Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Human Papillomavirus Protein E7 Sales (K Pcs) by Company (2016-2021)
Table 39. North America Human Papillomavirus Protein E7 Sales Market Share by Company (2016-2021)
Table 40. North America Human Papillomavirus Protein E7 Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Papillomavirus Protein E7 Revenue Market Share by Company (2016-2021)
Table 42. North America Human Papillomavirus Protein E7 Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Human Papillomavirus Protein E7 Sales Market Share by Type (2016-2021)
Table 44. North America Human Papillomavirus Protein E7 Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Human Papillomavirus Protein E7 Sales Market Share by Type (2022-2027)
Table 46. North America Human Papillomavirus Protein E7 Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Human Papillomavirus Protein E7 Sales Market Share by Application (2016-2021)
Table 48. North America Human Papillomavirus Protein E7 Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Human Papillomavirus Protein E7 Sales Market Share by Application (2022-2027)
Table 50. Europe Human Papillomavirus Protein E7 Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Human Papillomavirus Protein E7 Sales Market Share by Company (2016-2021)
Table 52. Europe Human Papillomavirus Protein E7 Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Papillomavirus Protein E7 Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Papillomavirus Protein E7 Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Human Papillomavirus Protein E7 Sales Market Share by Type (2016-2021)
Table 56. Europe Human Papillomavirus Protein E7 Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Human Papillomavirus Protein E7 Sales Market Share by Type (2022-2027)
Table 58. Europe Human Papillomavirus Protein E7 Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Human Papillomavirus Protein E7 Sales Market Share by Application (2016-2021)
Table 60. Europe Human Papillomavirus Protein E7 Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Human Papillomavirus Protein E7 Sales Market Share by Application (2022-2027)
Table 62. China Human Papillomavirus Protein E7 Sales (K Pcs) by Company (2016-2021)
Table 63. China Human Papillomavirus Protein E7 Sales Market Share by Company (2016-2021)
Table 64. China Human Papillomavirus Protein E7 Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Papillomavirus Protein E7 Revenue Market Share by Company (2016-2021)
Table 66. China Human Papillomavirus Protein E7 Sales by Type (2016-2021) & (K Pcs)
Table 67. China Human Papillomavirus Protein E7 Sales Market Share by Type (2016-2021)
Table 68. China Human Papillomavirus Protein E7 Sales by Type (2022-2027) & (K Pcs)
Table 69. China Human Papillomavirus Protein E7 Sales Market Share by Type (2022-2027)
Table 70. China Human Papillomavirus Protein E7 Sales by Application (2016-2021) & (K Pcs)
Table 71. China Human Papillomavirus Protein E7 Sales Market Share by Application (2016-2021)
Table 72. China Human Papillomavirus Protein E7 Sales by Application (2022-2027) & (K Pcs)
Table 73. China Human Papillomavirus Protein E7 Sales Market Share by Application (2022-2027)
Table 74. Japan Human Papillomavirus Protein E7 Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Human Papillomavirus Protein E7 Sales Market Share by Company (2016-2021)
Table 76. Japan Human Papillomavirus Protein E7 Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Papillomavirus Protein E7 Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Papillomavirus Protein E7 Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Human Papillomavirus Protein E7 Sales Market Share by Type (2016-2021)
Table 80. Japan Human Papillomavirus Protein E7 Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Human Papillomavirus Protein E7 Sales Market Share by Type (2022-2027)
Table 82. Japan Human Papillomavirus Protein E7 Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Human Papillomavirus Protein E7 Sales Market Share by Application (2016-2021)
Table 84. Japan Human Papillomavirus Protein E7 Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Human Papillomavirus Protein E7 Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Papillomavirus Protein E7 Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Human Papillomavirus Protein E7 Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Papillomavirus Protein E7 Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Papillomavirus Protein E7 Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Papillomavirus Protein E7 Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Human Papillomavirus Protein E7 Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Papillomavirus Protein E7 Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Human Papillomavirus Protein E7 Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Papillomavirus Protein E7 Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Human Papillomavirus Protein E7 Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Papillomavirus Protein E7 Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Human Papillomavirus Protein E7 Sales Market Share by Application (2022-2027)
Table 98. India Human Papillomavirus Protein E7 Sales (K Pcs) by Company (2016-2021)
Table 99. India Human Papillomavirus Protein E7 Sales Market Share by Company (2016-2021)
Table 100. India Human Papillomavirus Protein E7 Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Papillomavirus Protein E7 Revenue Market Share by Company (2016-2021)
Table 102. India Human Papillomavirus Protein E7 Sales by Type (2016-2021) & (K Pcs)
Table 103. India Human Papillomavirus Protein E7 Sales Market Share by Type (2016-2021)
Table 104. India Human Papillomavirus Protein E7 Sales by Type (2022-2027) & (K Pcs)
Table 105. India Human Papillomavirus Protein E7 Sales Market Share by Type (2022-2027)
Table 106. India Human Papillomavirus Protein E7 Sales by Application (2016-2021) & (K Pcs)
Table 107. India Human Papillomavirus Protein E7 Sales Market Share by Application (2016-2021)
Table 108. India Human Papillomavirus Protein E7 Sales by Application (2022-2027) & (K Pcs)
Table 109. India Human Papillomavirus Protein E7 Sales Market Share by Application (2022-2027)
Table 110. Abion Inc Corporation Information
Table 111. Abion Inc Description and Business Overview
Table 112. Abion Inc Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Abion Inc Human Papillomavirus Protein E7 Product
Table 114. Abion Inc Recent Development
Table 115. Advaxis Inc Corporation Information
Table 116. Advaxis Inc Description and Business Overview
Table 117. Advaxis Inc Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Advaxis Inc Human Papillomavirus Protein E7 Product
Table 119. Advaxis Inc Recent Development
Table 120. Bioleaders Corp Corporation Information
Table 121. Bioleaders Corp Description and Business Overview
Table 122. Bioleaders Corp Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Bioleaders Corp Human Papillomavirus Protein E7 Product
Table 124. Bioleaders Corp Recent Development
Table 125. BioNTech AG Corporation Information
Table 126. BioNTech AG Description and Business Overview
Table 127. BioNTech AG Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. BioNTech AG Human Papillomavirus Protein E7 Product
Table 129. BioNTech AG Recent Development
Table 130. Cancer Research Technology Ltd Corporation Information
Table 131. Cancer Research Technology Ltd Description and Business Overview
Table 132. Cancer Research Technology Ltd Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Cancer Research Technology Ltd Human Papillomavirus Protein E7 Product
Table 134. Cancer Research Technology Ltd Recent Development
Table 135. Etubics Corp Corporation Information
Table 136. Etubics Corp Description and Business Overview
Table 137. Etubics Corp Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Etubics Corp Human Papillomavirus Protein E7 Product
Table 139. Etubics Corp Recent Development
Table 140. Formune SL Corporation Information
Table 141. Formune SL Description and Business Overview
Table 142. Formune SL Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Formune SL Human Papillomavirus Protein E7 Product
Table 144. Formune SL Recent Development
Table 145. Genexine Inc Corporation Information
Table 146. Genexine Inc Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Genexine Inc Description and Business Overview
Table 148. Genexine Inc Human Papillomavirus Protein E7 Product
Table 149. Genexine Inc Recent Development
Table 150. Hookipa Biotech AG Corporation Information
Table 151. Hookipa Biotech AG Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Hookipa Biotech AG Description and Business Overview
Table 153. Hookipa Biotech AG Human Papillomavirus Protein E7 Product
Table 154. Hookipa Biotech AG Recent Development
Table 155. iBio Inc Corporation Information
Table 156. iBio Inc Description and Business Overview
Table 157. iBio Inc Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. iBio Inc Human Papillomavirus Protein E7 Product
Table 159. iBio Inc Recent Development
Table 160. Immunovaccine Inc Corporation Information
Table 161. Immunovaccine Inc Description and Business Overview
Table 162. Immunovaccine Inc Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Immunovaccine Inc Human Papillomavirus Protein E7 Product
Table 164. Immunovaccine Inc Recent Development
Table 165. Inovio Pharmaceuticals Inc Corporation Information
Table 166. Inovio Pharmaceuticals Inc Description and Business Overview
Table 167. Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Inovio Pharmaceuticals Inc Human Papillomavirus Protein E7 Product
Table 169. Inovio Pharmaceuticals Inc Recent Development
Table 170. MedImmune LLC Corporation Information
Table 171. MedImmune LLC Description and Business Overview
Table 172. MedImmune LLC Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. MedImmune LLC Human Papillomavirus Protein E7 Product
Table 174. MedImmune LLC Recent Development
Table 175. Selecta Biosciences Inc Corporation Information
Table 176. Selecta Biosciences Inc Description and Business Overview
Table 177. Selecta Biosciences Inc Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Selecta Biosciences Inc Human Papillomavirus Protein E7 Product
Table 179. Selecta Biosciences Inc Recent Development
Table 180. Touchlight Genetics Ltd Corporation Information
Table 181. Touchlight Genetics Ltd Description and Business Overview
Table 182. Touchlight Genetics Ltd Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Touchlight Genetics Ltd Human Papillomavirus Protein E7 Product
Table 184. Touchlight Genetics Ltd Recent Development
Table 185. Transgene SA Corporation Information
Table 186. Transgene SA Description and Business Overview
Table 187. Transgene SA Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Transgene SA Human Papillomavirus Protein E7 Product
Table 189. Transgene SA Recent Development
Table 190. VLPbio Corporation Information
Table 191. VLPbio Description and Business Overview
Table 192. VLPbio Human Papillomavirus Protein E7 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. VLPbio Human Papillomavirus Protein E7 Product
Table 194. VLPbio Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Human Papillomavirus Protein E7 Distributors List
Table 198. Human Papillomavirus Protein E7 Customers List
Table 199. Human Papillomavirus Protein E7 Market Trends
Table 200. Human Papillomavirus Protein E7 Market Drivers
Table 201. Human Papillomavirus Protein E7 Market Challenges
Table 202. Human Papillomavirus Protein E7 Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Papillomavirus Protein E7 Product Picture
Figure 2. Global Human Papillomavirus Protein E7 Sales Market Share by Type in 2021 & 2027
Figure 3. CUE-201 Product Picture
Figure 4. BLSILSB-710c Product Picture
Figure 5. CerviVax Product Picture
Figure 6. CUE-101 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Papillomavirus Protein E7 Sales Market Share by Application in 2021 & 2027
Figure 9. Anal Cancer Examples
Figure 10. Lung Cancer Examples
Figure 11. Penile Cancer Examples
Figure 12. Rectal Cancer Examples
Figure 13. Others Examples
Figure 14. Global Human Papillomavirus Protein E7 Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Human Papillomavirus Protein E7 Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Human Papillomavirus Protein E7 Sales (K Pcs) Growth Rate (2016-2027)
Figure 17. Global Human Papillomavirus Protein E7 Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 18. Global Human Papillomavirus Protein E7 Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Human Papillomavirus Protein E7 Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Human Papillomavirus Protein E7 Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Human Papillomavirus Protein E7 Sales (K Pcs) Growth Rate (2016-2027)
Figure 22. Europe Human Papillomavirus Protein E7 Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Human Papillomavirus Protein E7 Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Human Papillomavirus Protein E7 Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Human Papillomavirus Protein E7 Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Human Papillomavirus Protein E7 Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Human Papillomavirus Protein E7 Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Human Papillomavirus Protein E7 Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Human Papillomavirus Protein E7 Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India Human Papillomavirus Protein E7 Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India Human Papillomavirus Protein E7 Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest Human Papillomavirus Protein E7 Players Market Share by Revenue in Human Papillomavirus Protein E7: 2016 & 2020
Figure 33. Human Papillomavirus Protein E7 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global Human Papillomavirus Protein E7 Revenue Share by Type (2016-2021)
Figure 35. Global Human Papillomavirus Protein E7 Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global Human Papillomavirus Protein E7 Revenue Share by Application (2016-2021)
Figure 37. Global Human Papillomavirus Protein E7 Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Human Papillomavirus Protein E7 Sales Market Share by Type in 2020
Figure 39. North America Human Papillomavirus Protein E7 Sales Market Share by Application in 2020
Figure 40. Europe Human Papillomavirus Protein E7 Sales Market Share by Type in 2020
Figure 41. Europe Human Papillomavirus Protein E7 Sales Market Share by Application in 2020
Figure 42. China Human Papillomavirus Protein E7 Sales Market Share by Type in 2020
Figure 43. China Human Papillomavirus Protein E7 Sales Market Share by Application in 2020
Figure 44. Japan Human Papillomavirus Protein E7 Sales Market Share by Type in 2020
Figure 45. Japan Human Papillomavirus Protein E7 Sales Market Share by Application in 2020
Figure 46. Southeast Asia Human Papillomavirus Protein E7 Sales Market Share by Type in 2020
Figure 47. Southeast Asia Human Papillomavirus Protein E7 Sales Market Share by Application in 2020
Figure 48. India Human Papillomavirus Protein E7 Sales Market Share by Type in 2020
Figure 49. India Human Papillomavirus Protein E7 Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Human Papillomavirus Protein E7
Figure 52. Manufacturing Process Analysis of Human Papillomavirus Protein E7
Figure 53. Human Papillomavirus Protein E7 Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed